{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T10:45:14Z","timestamp":1772102714245,"version":"3.50.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["VCF-179243"],"award-info":[{"award-number":["VCF-179243"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014565","name":"Bausch Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010882","name":"Australasian Society of Clinical Immunology and Allergy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jacig.2023.100079","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T19:23:19Z","timestamp":1675884199000},"page":"100079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Vaccine confidence among those living with allergy during the COVID pandemic (ACCORD): A\u00a0scoping review"],"prefix":"10.1016","volume":"2","author":[{"given":"Ayel Luis R.","family":"Batac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlyn A.","family":"Merrill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Askin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Golding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elissa M.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"B\u00e9gin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Ben-Shoshan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Ladouceur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie E.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladan","family":"Protudjer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.P.","family":"Protudjer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2023.100079_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jad.2020.07.081","article-title":"Maternal psychological distress a mental health service use during the COVID-19 pandemic","volume":"276","author":"Cameron","year":"2020","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jacig.2023.100079_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.anai.2020.09.010","article-title":"High anxiety and health-related quality of life in families with children with food allergy during coronavirus disease 2019","volume":"126","author":"Protudjer","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2023.100079_bib3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1037\/cbs0000280","article-title":"COVID-19-related media consumption and parental mental health","volume":"53","author":"Golding","year":"2021","journal-title":"Can J Behav Sci Rev"},{"key":"10.1016\/j.jacig.2023.100079_bib5","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.2196\/jmir.8.2.e9","article-title":"eHealth literacy: essential skills for consumer health in a networked world","volume":"8","author":"Norman","year":"2006","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.jacig.2023.100079_bib6","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1080\/21645515.2020.1780846","article-title":"Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases","volume":"16","author":"Puri","year":"2020","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.jacig.2023.100079_bib8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10654-020-00671-y","article-title":"Vaccine hesitancy: the next challenge in the fight against COVID-19","volume":"35","author":"Dror","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jacig.2023.100079_bib9","doi-asserted-by":"crossref","unstructured":"US Centers for Disease Control and Prevention, Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine - United States, December 21, 2020-January 10, 2021, Available at: https:\/\/www.cdc.gov\/mmwr\/volumes\/70\/wr\/mm7004e1.htm#suggestedcitation. Accessed May 7, 2022","DOI":"10.15585\/mmwr.mm7004e1"},{"key":"10.1016\/j.jacig.2023.100079_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajic.2021.10.015","article-title":"The safety profile of COVID-19 vaccinations in the United States","volume":"50","author":"Singh","year":"2022","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jacig.2023.100079_bib12","doi-asserted-by":"crossref","unstructured":"Hourihane JO, Byrne AM, Bl\u00fcmchen K, Turner PJ, Greenhawt M. Ascertainment bias in anaphylaxis safety data of COVID-19 vaccines. J Allergy Clin Immunol Pract 2021;9:2562-6.","DOI":"10.1016\/j.jaip.2021.04.025"},{"key":"10.1016\/j.jacig.2023.100079_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2021.100622","article-title":"Experience of the first 1127 COVID-19 vaccine allergy safety patients in Hong Kong - clinical outcomes, barriers to vaccination, and urgency for reform","volume":"15","author":"Chiang","year":"2022","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jacig.2023.100079_bib14","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hec.3937","article-title":"Vaccine hesitancy and (fake) news: quasi-experimental evidence from Italy","volume":"28","author":"Carrieri","year":"2019","journal-title":"Health Econ"},{"key":"10.1016\/j.jacig.2023.100079_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.anai.2021.03.012","article-title":"Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions: early report","volume":"126","author":"Pitlick","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2023.100079_bib17","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/all.14711","article-title":"Allergic reactions to the first COVID-19 vaccine: a potential role of polyethylene glycol?","volume":"76","author":"Cabanillas","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2023.100079_bib18","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/all.15183","article-title":"Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis","volume":"77","author":"Brockow","year":"2022","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100079_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.anai.2021.11.006","article-title":"Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions","volume":"128","author":"Pitlick","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2023.100079_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100654","article-title":"Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose - a single center experience","volume":"15","author":"Puxkandl","year":"2022","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jacig.2023.100079_bib21","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1111\/all.15414","article-title":"Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity","volume":"77","author":"Worm","year":"2022","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100079_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13223-022-00698-8","article-title":"Successful mRNA COVID-19 vaccination in a patient with a history of severe polyethylene glycol anaphylaxis","volume":"18","author":"Li","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100079_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol"},{"key":"10.1016\/j.jacig.2023.100079_bib24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacig.2023.100079_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13223-022-00723-w","article-title":"Vaccine confidence amongst those living with allergy during the COVID pandemic\u00a0(ACCORD): a scoping review protocol","volume":"18","author":"Golding","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100079_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS peer review of electronic search strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jacig.2023.100079_bib27","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1001\/jama.2021.3976","article-title":"Acute allergic reactions to mRNA COVID-19 vaccines","volume":"325","author":"Blumenthal","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacig.2023.100079_bib28","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for adverse events after COVID-19 mRNA vaccination","volume":"326","author":"Klein","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacig.2023.100079_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.25524","article-title":"Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system","volume":"4","author":"Warren","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacig.2023.100079_bib30","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1111\/all.14958","article-title":"Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: don\u2019t give up on the second dose!","volume":"76","author":"Krantz","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2023.100079_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.anai.2021.10.019","article-title":"Allergic reactions to coronavirus disease 2019 vaccines and addressing vaccine hesitancy: Northwell Health experience","volume":"128","author":"Kaplan","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2023.100079_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imj.15623","article-title":"Pfizer\/BioNtech BNT162b2: adverse events and insights from an Australian mass vaccination clinic for COVID-19","volume":"52","author":"Halder","year":"2022","journal-title":"Intern Med J"},{"key":"10.1016\/j.jacig.2023.100079_bib33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.47102\/annals-acadmedsg.2021345","article-title":"Adverse reactions and safety profile of the mRNA COVID-19 vaccines among Asian military personnel","volume":"50","author":"Tan","year":"2021","journal-title":"Ann Acad Med Singap"},{"key":"10.1016\/j.jacig.2023.100079_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2021.103044","article-title":"Adverse reactions following COVID-19 vaccination: an Ecuadorian experience","volume":"72","author":"Vanegas","year":"2021","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.jacig.2023.100079_bib35","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1016\/j.jaip.2021.05.031","article-title":"Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination","volume":"9","author":"Robinson","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2023.100079_bib36","doi-asserted-by":"crossref","first-page":"e1104","DOI":"10.1212\/NXI.0000000000001104","article-title":"COVID-19 vaccination reactogenicity in persons with multiple sclerosis","volume":"9","author":"Briggs","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.jacig.2023.100079_bib37","article-title":"Three doses of COVID-19 mRNA vaccination are safe based on adverse events reported in electronic health records","author":"Niesen","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.jacig.2023.100079_bib38","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 - preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2023.100079_bib39","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2023.100079_bib40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 caccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2023.100079_bib41","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa2116185","article-title":"Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico","volume":"386","author":"Dunkle","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2023.100079_bib42","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1056\/NEJMoa2105290","article-title":"Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 vaccine","volume":"385","author":"Falsey","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2023.100079_bib43","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1056\/NEJMoa2201300","article-title":"Efficacy and safety of a recombinant plant-based adjuvanted Covid-19 vaccine","volume":"386","author":"Hager","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2023.100079_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(21)01429-X","article-title":"Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey","volume":"398","author":"Tanriover","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2023.100079_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2023.100079_bib46","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.31034","article-title":"Association of self-reported high-risk allergy history with allergy symptoms after COVID-19 vaccination","volume":"4","author":"Li","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacig.2023.100079_bib47","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/jama.2021.1967","article-title":"Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US\u2013December 14, 2020-January 18, 2021","volume":"325","author":"Shimabukuro","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacig.2023.100079_bib48","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.1016\/j.vaccine.2021.09.048","article-title":"Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine","volume":"39","author":"Yacoub","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jacig.2023.100079_bib49","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.22255","article-title":"Prevalence of allergic reactions after Pfizer-BioNTech COVID-19 vaccination among adults with high allergy risk","volume":"4","author":"Shavit","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacig.2023.100079_bib50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/diseases9030058","article-title":"Skin adverse reactions to novel messenger RNA coronavirus vaccination: a case series","volume":"9","author":"Peigottu","year":"2021","journal-title":"Diseases"},{"key":"10.1016\/j.jacig.2023.100079_bib51","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2500\/aap.2022.43.210101","article-title":"Delayed systemic urticarial reactions following mRNA COVID-19 vaccination","volume":"43","author":"Pitlick","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jacig.2023.100079_bib52","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/00325481.2021.1999708","article-title":"Adverse events report of inactivated COVID-19 vaccine from 4040 healthcare workers","volume":"134","author":"Tosun","year":"2022","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jacig.2023.100079_bib53","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1016\/j.vaccine.2021.06.061","article-title":"Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site","volume":"39","author":"Myles","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jacig.2023.100079_bib54","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cea.14064","article-title":"The polysorbate containing AstraZeneca COVID-19 vaccine is tolerated by polyethylene glycol (PEG) allergic patients","volume":"52","author":"Sellaturay","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jacig.2023.100079_bib56","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.anai.2021.04.004","article-title":"Disproportionality analysis of anaphylactic reactions after vaccination with messenger RNA coronavirus disease 2019 vaccines in the United States","volume":"127","author":"Rodriguez-Nava","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2023.100079_bib57","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.40364","article-title":"Analysis of COVID-19 vaccine type and adverse effects following vaccination","volume":"4","author":"Beatty","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacig.2023.100079_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2021.102207","article-title":"Potential adverse effects of COVID19 vaccines among Iraqi population; a comparison between the three available vaccines in Iraq; a retrospective cross-sectional study","volume":"15","author":"Almufty","year":"2021","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.jacig.2023.100079_bib59","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.vaccine.2022.01.062","article-title":"Self-reported reactogenicity of CoronaVac (Sinovac) compared with Comirnaty (Pfizer-BioNTech): a prospective cohort study with intensive monitoring","volume":"40","author":"Lai","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.jacig.2023.100079_bib60","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1002\/jmv.27214","article-title":"Safety of COVID-19 vaccines","volume":"93","author":"Al Khames Aga","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.jacig.2023.100079_bib61","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2500\/aap.2021.42.210069","article-title":"Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A\u00a0health-care system experience","volume":"42","author":"Arroliga","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jacig.2023.100079_bib62","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5336\/dermato.2021-85208","article-title":"Local and systemic adverse effects of CoronaVac vaccine in risk groups: prospective, cross-sectional study","volume":"31","author":"Dogan","year":"2021","journal-title":"Turkiye Klinikleri J Dermatol"},{"key":"10.1016\/j.jacig.2023.100079_bib63","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/all.15148","article-title":"The value of the basophil activation test in the evaluation of patients reporting allergic\u00a0reactions to the BNT162b2 mRNA COVID-19 vaccine","volume":"77","author":"Labella","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2023.100079_bib64","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1016\/j.jaip.2021.07.010","article-title":"An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history","volume":"9","author":"Krantz","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2023.100079_bib65","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/cea.13874","article-title":"Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer\/BioNTech mRNA COVID-19 vaccine","volume":"51","author":"Sellaturay","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jacig.2023.100079_bib66","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1016\/j.jaip.2021.07.012","article-title":"Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19","volume":"9","author":"Ju\u00e1rez Guerrero","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2023.100079_bib67","unstructured":"World Health Organization 24th, WHO Regulatory Update on COVID-19. 2020. Available at: https:\/\/www.who.int\/docs\/default-source\/medicines\/regulatory-updates\/covid-19\/24th-who-regulatory-update-on-covid-19_11dec2020.pdf?sfvrsn=1df78a5_3. Accessed May 21, 2022."},{"key":"10.1016\/j.jacig.2023.100079_bib68","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1001\/jamainternmed.2021.3779","article-title":"Safety evaluation of the second dose of messenger RNA COVID-19 vaccines in patients\u00a0with immediate reactions to the first dose","volume":"181","author":"Krantz","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacig.2023.100079_bib69","doi-asserted-by":"crossref","first-page":"730","DOI":"10.5005\/jp-journals-10024-3114","article-title":"Acceptance and attitude toward COVID-19 vaccination among the public in Saudi Arabia: a cross-sectional study","volume":"22","author":"Alduwayghiri","year":"2021","journal-title":"J Contemp Dent Pract"},{"key":"10.1016\/j.jacig.2023.100079_bib70","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1093\/rheumatology\/keab169","article-title":"Survey of adult and paediatric rheumatology patients suggests information about COVID-19 vaccination will aid uptake","volume":"60","author":"Beesley","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.jacig.2023.100079_bib71","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejca.2021.05.006","article-title":"The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: early data from a single-institute survey","volume":"153","author":"Di Noia","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jacig.2023.100079_bib72","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40545-021-00403-x","article-title":"Assessment of COVID-19 vaccines acceptance in the Lebanese population: a national cross-sectional study","volume":"15","author":"Hanna","year":"2022","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/j.jacig.2023.100079_bib73","first-page":"1973","article-title":"Survey on attitude towards COVID-19 vaccines and analysis of reasons for vaccine hesitancy among public in Tamil Nadu during the second wave of COVID-19 pandemic","volume":"3","author":"Kanchana","year":"2021","journal-title":"Pharmacologyonline"},{"key":"10.1016\/j.jacig.2023.100079_bib74","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.dsx.2021.02.031","article-title":"Analyzing the attitude of Indian citizens towards COVID-19 vaccine - a text analytics study","volume":"15","author":"Praveen","year":"2021","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.jacig.2023.100079_bib75","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/vaccines9040382","article-title":"The perception and attitudes toward COVID-19 vaccines: a cross-sectional study in Poland","volume":"9","author":"Rzymski","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jacig.2023.100079_bib76","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/vaccines9101172","article-title":"Public willingness and determinants of COVID-19 vaccination at the initial stage of mass vaccination in China","volume":"9","author":"Zhao","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jacig.2023.100079_bib77","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/nursrep11010018","article-title":"Healthcare provider attitudes toward the newly developed COVID-19 vaccine: cross-sectional study","volume":"11","author":"Ahmed","year":"2021","journal-title":"Nurs Rep"},{"key":"10.1016\/j.jacig.2023.100079_bib78","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1159\/000517793","article-title":"First-dose coronavirus 2019 vaccination coverage among the residents of long-term care facilities in France","volume":"68","author":"Belmin","year":"2022","journal-title":"Gerontology"},{"key":"10.1016\/j.jacig.2023.100079_bib79","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/14760584.2022.2016401","article-title":"Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China","volume":"21","author":"Tung","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jacig.2023.100079_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2021.1949950","article-title":"COVID-19 vaccination in Chinese children: a cross-sectional study on the cognition, psychological anxiety state and the willingness toward vaccination","volume":"18","author":"Yang","year":"2022","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.jacig.2023.100079_bib81","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1016\/j.jaip.2021.06.006","article-title":"The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach","volume":"9","author":"Greenhawt","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2023.100079_bib82","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1016\/j.vaccine.2013.10.033","article-title":"Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A\/H1N1 (H1N1pdm09) vaccine","volume":"31","author":"Rouleau","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jacig.2023.100079_bib83","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jaci.2015.07.048","article-title":"Risk of anaphylaxis after vaccination in children and adults","volume":"137","author":"McNeil","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100079_bib84","doi-asserted-by":"crossref","first-page":"m4780","DOI":"10.1136\/bmj.m4780","article-title":"Covid-19: people with history of significant allergic reactions should not receive Pfizer vaccine, says regulator","volume":"371","author":"Mahase","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jacig.2023.100079_bib85","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.jaip.2021.03.053","article-title":"COVID-19 vaccination in patients with reported allergic reactions: updated\u00a0evidence and suggested approach","volume":"9","author":"Banerji","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2023.100079_bib86","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/19434471003768826","article-title":"After years of media coverage, can\u00a0one more video report trigger heuristic judgments? A\u00a0national study of\u00a0American terrorism risk perceptions","volume":"2","author":"Breckenridge","year":"2010","journal-title":"Behav Sci Terror Polit Aggress"},{"key":"10.1016\/j.jacig.2023.100079_bib87","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1539-6924.2006.00773.x","article-title":"The role of the affect and availability heuristics in risk communication","volume":"26","author":"Keller","year":"2006","journal-title":"Risk Anal"},{"key":"10.1016\/j.jacig.2023.100079_bib88","doi-asserted-by":"crossref","unstructured":"Kavanagh J, Carman KG, DeYoreo M, Chandler N, Davis LE. the drivers of institutional trust and distrust: exploring components of trustworthiness. Santa Monica, CA: RAND Corporation; 2020. Available at: https:\/\/www.rand.org\/pubs\/research_reports\/RRA112-7.html Accessed June 3, 2022.","DOI":"10.7249\/RRA112-7"},{"key":"10.1016\/j.jacig.2023.100079_bib89","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-reporting of adverse drug reactions: a systematic review","volume":"29","author":"Hazell","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.jacig.2023.100079_bib90","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.anai.2021.05.011","article-title":"Primary care provider-reported prevalence of vaccine and polyethylene glycol allergy in Canada","volume":"127","author":"Abrams","year":"2021","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829323000048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829323000048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:20:31Z","timestamp":1762647631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829323000048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2772829323000048"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2023.100079","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine confidence among those living with allergy during the COVID pandemic (ACCORD): A\u00a0scoping review","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2023.100079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100079"}}